Aegerion Pharma Inc (AEGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 239,887 | 158,373 | 48,546 | 0 | 0 |
| Cost of Goods | 52,332 | 14,370 | 5,019 | N/A | N/A |
| Gross Profit | 187,555 | 144,003 | 43,527 | N/A | N/A |
| Operating Expenses | 233,073 | 171,075 | 105,893 | 60,607 | 39,311 |
| Operating Income | -45,186 | -26,702 | -62,347 | -60,607 | -39,311 |
| Interest Expense | 27,605 | 9,691 | 453 | 937 | 1,114 |
| Other Income | 1,221 | -2,093 | -211 | -721 | 957 |
| Pre-tax Income | -71,570 | -38,486 | -63,011 | -62,265 | -39,468 |
| Income Tax | 1,769 | 899 | 347 | N/A | N/A |
| Net Income Continuous | -73,339 | -39,385 | -63,358 | -62,265 | -39,468 |
| Net Income | $-73,339 | $-39,385 | $-63,358 | $-62,265 | $-39,468 |
| EPS Basic Total Ops | -2.55 | -1.35 | -2.19 | -2.64 | -2.03 |
| EPS Basic Continuous Ops | -2.55 | -1.35 | -2.19 | -2.64 | -2.03 |
| EPS Diluted Total Ops | -2.55 | -1.35 | -2.19 | -2.64 | -2.03 |
| EPS Diluted Continuous Ops | -2.55 | -1.35 | -2.19 | -2.64 | -2.03 |
| EPS Diluted Before Non-Recurring Items | -1.06 | -1.10 | -2.19 | -2.58 | -1.99 |
| EBITDA(a) | $-23,188 | $-24,418 | $-59,974 | $-59,378 | $-38,904 |